S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
AI Stock Caught Trading Under Secret Name (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
AI Stock Caught Trading Under Secret Name (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
AI Stock Caught Trading Under Secret Name (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
AI Stock Caught Trading Under Secret Name (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture
NASDAQ:INVO

INVO Bioscience (INVO) Stock Price, News & Analysis

$1.01
+0.09 (+9.78%)
(As of 02/23/2024 ET)
Today's Range
$0.90
$1.02
50-Day Range
$0.85
$1.44
52-Week Range
$0.50
$16.40
Volume
20,763 shs
Average Volume
19,182 shs
Market Capitalization
$2.49 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

INVO stock logo

About INVO Bioscience Stock (NASDAQ:INVO)

INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. INVO Bioscience, Inc. was founded in 2007 and is based in Sarasota, Florida.

INVO Stock Price History

INVO Stock News Headlines

INVO Bioscience Inc INVO
My wife was skeptical... until I showed her my account balance.
The Fed just created the single greatest income opportunity I've seen in nearly 20 years. I've put more than $1M of my own money into it. And plan to add another million! I even suggested my wife put her savings into it.    
Wall Street Pushing a 'Crypto Revolution' - Will You Miss Out… AGAIN?
Financial giants have been injecting millions into the crypto market. The big players are going all in on crypto… but what are they gearing up for? There is a significant event on the horizon that will shape the future of Bitcoin—the upcoming Bitcoin halving event…We're revealing all the secrets behind the financial elite's bold moves in crypto during our LIVE, online event.
INVO Reports Record Third Quarter 2023 Financial Results
What's Going On With INVO BioScience Stock?
BHAT and INVO among pre-market losers
See More Headlines
Receive INVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for INVO Bioscience and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/15/2021
Today
2/24/2024
Next Earnings (Estimated)
4/15/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:INVO
Fax
N/A
Employees
15
Year Founded
N/A

Profitability

Net Income
$-10,890,000.00
Net Margins
-459.42%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$820,000.00
Book Value
($1.61) per share

Miscellaneous

Free Float
2,388,000
Market Cap
$2.49 million
Optionable
Optionable
Beta
1.42
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Mr. Steven M. Shum (Age 53)
    CEO & Director
    Comp: $260k
  • Mr. Andrea  GorenMr. Andrea Goren (Age 57)
    Chief Financial Officer
    Comp: $215k
  • Mr. Michael Jos. Campbell (Age 66)
    COO & VP of Business Development
    Comp: $220k
  • Mr. Bojan Mitrovic Ph.D.
    Director of Sales US
  • Mr. Robert Joseph Bowdring Jr. (Age 66)
    Treasurer & Secretary
  • Ms. Terah Krigsvold
    Controller














INVO Stock Analysis - Frequently Asked Questions

How have INVO shares performed in 2024?

INVO Bioscience's stock was trading at $1.35 at the beginning of 2024. Since then, INVO stock has decreased by 25.2% and is now trading at $1.01.
View the best growth stocks for 2024 here
.

When is INVO Bioscience's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, April 15th 2024.
View our INVO earnings forecast
.

How were INVO Bioscience's earnings last quarter?

INVO Bioscience, Inc. (NASDAQ:INVO) issued its earnings results on Monday, November, 15th. The company reported ($4.80) EPS for the quarter, missing analysts' consensus estimates of ($4.00) by $0.80. The company had revenue of $0.22 million for the quarter, compared to analyst estimates of $0.25 million. INVO Bioscience had a negative trailing twelve-month return on equity of 7,630.09% and a negative net margin of 459.42%. During the same period in the previous year, the business posted ($7.20) EPS.

When did INVO Bioscience's stock split?

Shares of INVO Bioscience reverse split on the morning of Thursday, July 27th 2023. The 1-20 reverse split was announced on Thursday, July 27th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, July 27th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Who are INVO Bioscience's major shareholders?

INVO Bioscience's stock is owned by a number of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (2.18%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Andrea Goren, Awm Investment Company, Inc, Matthew K Szot, Michael Jos Campbell and Steve Shum.
View institutional ownership trends
.

How do I buy shares of INVO Bioscience?

Shares of INVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:INVO) was last updated on 2/25/2024 by MarketBeat.com Staff